Breast cancer, Secondary cancers
Results
Phase 3
This trial looked at adding a drug called veliparib to chemotherapy for breast cancer.
It was for people with breast cancer with all of the following. The cancer:
had spread into tissue surrounding the breast or to another part of the body
had the or gene change (mutation)
was HER2 negative
This trial was open for people to join between 2014 and 2017. The team published the results in 2020.
Recruitment start: 26 June 2014
Recruitment end: 30 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Stephen Chan
AbbVie
Last reviewed: 10 Jun 2021
CRUK internal database number: 13041
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
